Szekanecz Z, Koch AE: Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol. 2007, 19: 289-95. 10.1097/BOR.0b013e32805e87ae.
Article
PubMed
Google Scholar
Hadjidakis DJ, Androulakis II: Bone remodeling. Ann N Y Acad Sci. 2006, 1092: 385-96. 10.1196/annals.1365.035.
Article
CAS
PubMed
Google Scholar
Giuliani N, Morandi F, Tagliaferri S, Rizzoli V: Targeting pathways mediating bone disease. Curr Pharm Biotechnol. 2006, 7: 423-9. 10.2174/138920106779116955.
Article
CAS
PubMed
Google Scholar
Blair HC, Zaidi M: Osteoclastic differentiation and function regulated by old and new pathways. Rev Endocr Metab Disord. 2006, 7: 23-32. 10.1007/s11154-006-9010-4.
Article
CAS
PubMed
Google Scholar
Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, Kodama T, Takai T, Miyasaka N, Takayanagi H: Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci USA. 2007, 104: 11394-11399. 10.1073/pnas.0701971104.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schett G: Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther. 2007, 9: 203-10.1186/ar2110.
Article
PubMed
PubMed Central
Google Scholar
Haynes DR: Emerging and future therapies for the treatment of bone loss associated with chronic inflammation. Inflammopharmacology. 2006, 14: 193-7. 10.1007/s10787-006-0006-1.
Article
CAS
PubMed
Google Scholar
Tremoulet AH, Albani S: Novel therapies for rheumatoid arthritis. Expert Opin Investig Drugs. 2006, 15: 1427-41. 10.1517/13543784.15.11.1427.
Article
CAS
PubMed
Google Scholar
Boyce BF, Schwarz EM, Xing L: Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr Opin Rheumatol. 2006, 18: 427-32. 10.1097/01.bor.0000231913.32364.32.
Article
CAS
PubMed
Google Scholar
Sato K, Takayanagi H: Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006, 18: 419-26. 10.1097/01.bor.0000231912.24740.a5.
Article
CAS
PubMed
Google Scholar
Teitelbaum SL: Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther. 2006, 8: 201-10.1186/ar1857.
Article
PubMed
Google Scholar
Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Min SY, Cho YG, Park SH, Kim HY: Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett. 2007, 110: 54-64. 10.1016/j.imlet.2007.03.004.
Article
CAS
PubMed
Google Scholar
Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L, Cirulli N, Mancini L, Corrado A, Grassi FR, Grano M: Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol. 2007, 212: 47-55. 10.1002/path.2153.
Article
CAS
PubMed
Google Scholar
Tanishima S, Kishimoto Y, Fukata S, Mizumura H, Hagino H, Teshima R: Minodronic acid influences receptor activator of nuclear factor kB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis. Mod Rheumatol. 2007, 17: 198-205. 10.1007/s10165-007-0566-y.
Article
CAS
PubMed
Google Scholar
Kitahara K, Kawai S: Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2007, 19: 238-45. 10.1097/BOR.0b013e328099af80.
Article
CAS
PubMed
Google Scholar
Gillespie MT: Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res Ther. 2007, 9: 103-10.1186/ar2141.
Article
PubMed
PubMed Central
Google Scholar
Suematsu A, Tajiri Y, Nakashima T, Taka J, Ochi S, Oda H, Nakamura K, Tanaka S, Takayanagi H: Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis. Mod Rheumatol. 2007, 17: 17-23. 10.1007/s10165-006-0531-1.
Article
CAS
PubMed
Google Scholar
Shu G, Yamamoto K, Nagashima M: Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. Mod Rheumatol. 2006, 16: 343-9. 10.1007/s10165-006-0515-1.
Article
CAS
PubMed
Google Scholar
Haynes DR: Emerging and future therapies for the treatment of bone loss associated with chronic inflammation. Inflammopharmacology. 2006, 14: 193-7. 10.1007/s10787-006-0006-1.
Article
CAS
PubMed
Google Scholar
Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A: Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res. 2007, 25: 304-10. 10.1002/jor.20317.
Article
CAS
PubMed
Google Scholar
Croom KF, Scott LJ: Intravenous ibandronate: in the treatment of osteoporosis. Drugs. 2006, 66: 1593-601. 10.2165/00003495-200666120-00005.
Article
CAS
PubMed
Google Scholar
Chapurlat RD, Delmas PD: Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab. 2006, 2: 211-9. 10.1038/ncpendmet0121.
Article
CAS
PubMed
Google Scholar
Manette C, Collette J, Sarlet N, Tancredi A, Zegels B, Reginster JY: Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate. Curr Med Chem. 2006, 13: 1585-90. 10.2174/092986706777442057.
Article
CAS
PubMed
Google Scholar
Cicek M, Oursler MJ: Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev. 2006, 25: 635-44. 10.1007/s10555-006-9035-x.
Article
CAS
PubMed
Google Scholar
Lipton A: Future treatment of bone metastases. Clin Cancer Res. 2006, 12 (20 Pt 2): 6305s-6308s. 10.1158/1078-0432.CCR-06-1157.
Article
CAS
PubMed
Google Scholar
Bagi CM: Targeting of therapeutic agents to bone to treat metastatic cancer. Adv Drug Deliv Rev. 2005, 57: 995-1010. 10.1016/j.addr.2004.12.014.
Article
CAS
PubMed
Google Scholar
Kanakis I, Kousidou OCh, Karamanos NK: In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease. In Vivo. 2005, 19: 311-8.
CAS
PubMed
Google Scholar
Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM: Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res. 2007, 21: 99-112. 10.1002/ptr.2030.
Article
PubMed
Google Scholar
New SA: Intake of fruit and vegetables: implications for bone health. Proc Nutr Soc. 2003, 62: 889-99.
PubMed
Google Scholar
Hidaka S, Okamoto Y, Yamada Y, Kon Y, Kimura TA: Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats. Phytother Res. 1999, 13: 14-9. 10.1002/(SICI)1099-1573(199902)13:1<14::AID-PTR375>3.0.CO;2-V.
Article
CAS
PubMed
Google Scholar
Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM, Timmermann BN: Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 2006, 69: 351-5. 10.1021/np050327j.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramprasath VR, Shanthi P, Sachdanandam P: Curative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis – with special reference to bone metabolism. Chem Biol Interact. 2006, 160: 183-92. 10.1016/j.cbi.2005.11.009.
Article
CAS
PubMed
Google Scholar
Sohail MT, Chaudhry MI, Usman MK, Mian T, Ishaq MN: Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders. Phytother Res. 2005, 19: 365-8. 10.1002/ptr.1680.
Article
CAS
PubMed
Google Scholar
Yin J, Tezuka Y, Kouda K, Le Tran Q, Miyahara T, Chen Y, Kadota S: Antiosteporotic activity of the water extract of Dioscorea spongiosa . Biol Pharm Bull. 2004, 27: 583-586. 10.1248/bpb.27.583.
Article
CAS
PubMed
Google Scholar
Wang D, Li F, Jiang Z: Osteoblastic proliferation stimulating activity of Psoralea corylifollia extracts and two of its flavonoids. Planta Med. 2001, 67: 748-749.
Article
CAS
PubMed
Google Scholar
Meng F, Xiong Z, Sun Y, Li F: Coumarins from Cidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells. Pharmazie. 2004, 59: 643-645.
CAS
PubMed
Google Scholar
Anila L, Vijayalakshmi NR: Flavonoids from Emblica officinalis and Mangifera indica, effectiveness for dyslipidemia. J Ethnopharmacol. 2002, 79: 81-87. 10.1016/S0378-8741(01)00361-0.
Article
CAS
PubMed
Google Scholar
Thakur CP, Mandal K: Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits Indian. J Med Res. 1984, 79: 142-146.
CAS
Google Scholar
Bhattacharya A, Kumar M, Ghosal S, Bhattacharya SK: Effect of bioactive tannoid principles of Emblica officinalis on iron-indued hepatic toxicity in rats. Phytomedicine. 2000, 7: 173-175.
Article
CAS
PubMed
Google Scholar
Ahmad I, Mehmood Z, Mohammad F: Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998, 62: 183-93. 10.1016/S0378-8741(98)00055-5.
Article
CAS
PubMed
Google Scholar
Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H: Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol. 1993, 45: 581-584.
Article
CAS
PubMed
Google Scholar
Jeena KJ, Kuttan G, Kuttan R: Antitumor activity of Emblica officinalis. J of Ethnoph. 2001, 75: 65-69. 10.1016/S0378-8741(00)00378-0.
Article
Google Scholar
Sancheti G, Jindal A, Kumari R, Goyal PK: Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev. 2005, 6: 197-201.
PubMed
Google Scholar
Sultana S, Ahmad S, Khan N, Jahangir T: Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J Exp Biol. 2005, 43: 430-6.
PubMed
Google Scholar
Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C: Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacology. 2006, 104: 113-8. 10.1016/j.jep.2005.08.065.
Article
CAS
PubMed
Google Scholar
Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I, Naccari R, Siciliani G, Gambari R: Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol. 2003, 66: 1189-98. 10.1016/S0006-2952(03)00470-2.
Article
CAS
PubMed
Google Scholar
Piva R, Penolazzi L, Lambertini E, Giordano S, Gambari R: Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis. 2005, 10: 1079-94. 10.1007/s10495-005-0618-8.
Article
CAS
PubMed
Google Scholar
Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N, Mischiati C, Gambari R: Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem. 2003, 278: 7500-9. 10.1074/jbc.M206780200.
Article
CAS
PubMed
Google Scholar
Piva R, Penolazzi L, Zennaro M, Bianchini E, Magri E, Borgatti M, Lampronti I, Lambertini E, Tavanti E, Gambari R: Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules. Ann N Y Acad Sci. 2006, 1091: 509-16. 10.1196/annals.1378.092.
Article
CAS
PubMed
Google Scholar
Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY: NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med. 2007, 13: 62-9. 10.1038/nm1519.
Article
CAS
PubMed
Google Scholar
Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF: NF-{kappa}B p50 and p52 Regulate Receptor Activator of NF-{kappa}B Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1. J Biol Chem. 2007, 282: 18245-53. 10.1074/jbc.M610701200.
Article
CAS
PubMed
Google Scholar
Matsuzaki K, Katayama K, Takahashi Y, Nakamura I, Udagawa N, Tsurukai T, Nishinakamura R, Toyama Y, Yabe Y, Hori M, Takahashi N, Suda T: Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology. 1999, 140: 925-32. 10.1210/en.140.2.925.
Article
CAS
PubMed
Google Scholar
Villanova I, Townsend PA, Uhlmann E, Knolle J, Peyman A, Amling M, Baron R, Horton MA, Teti A: Oligodeoxynucleotide targeted to the alphav gene inhibits alphav integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis. J Bone Miner Res. 1999, 14: 1867-79. 10.1359/jbmr.1999.14.11.1867.
Article
CAS
PubMed
Google Scholar
Khan MTH, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri SMK, Datta BK, Gambari R: Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica Officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol. 2002, 20: 187-192.
Google Scholar
Lampronti I, Martello D, Bianchi N, Borgatti M, Lambertini E, Piva R, Jabbar S, Shahabuddin Kabir Choudhuri M, Tareq Hassan Khan M, Gambari R: In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa. Phytomedicine. 2003, 10: 300-308. 10.1078/094471103322004794.
Article
CAS
PubMed
Google Scholar
Denizot F, Lang RJ: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Immunol Meth. 1986, 22: 271-277. 10.1016/0022-1759(86)90368-6.
Article
Google Scholar
Lampronti I, Khan MTH, Borgatti M, Bianchi N, Gambari R: Inhibitory effects of Bangladeshi medicinal plant extracts on interaction teween transcription factors and target DNA sequences. Evidence-based Complementary and Alternative Medicine. 2007
Google Scholar
Pritts T, Hungness E, Wang Q, Robb B, Hershko D, Hasselgren PO: Mucosal and enterocyte IL-6 production during sepsis and endotoxemia – role of transcription factors and regulation by the stress response. Am J Surg. 2002, 183: 372-83. 10.1016/S0002-9610(02)00812-7.
Article
CAS
PubMed
Google Scholar
Domingo-Domenech J, Oliva C, Rovira A, Codony-Servat J, Bosch M, Filella X, Montagut C, Tapia M, Campas C, Dang L, Rolfe M, Ross JS, Gascon P, Albanell J, Mellado B: Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res. 2006, 12: 5578-86. 10.1158/1078-0432.CCR-05-2767.
Article
CAS
PubMed
Google Scholar
Ameye LG, Chee WS: Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006, 8: R127-10.1186/ar2016.
Article
PubMed
PubMed Central
Google Scholar
Idris A, Mrak E, Greig I, Guidobono F, Ralston SH, van't Hof R: ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways. Biochem Biophys Res Commun. 2008, 371: 94-8. 10.1016/j.bbrc.2008.04.014.
Article
CAS
PubMed
Google Scholar
Uchiyama S, Yamaguchi M: Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. J Cell Biochem. 2007, 101: 529-42. 10.1002/jcb.21208.
Article
CAS
PubMed
Google Scholar
Do SH, Lee JW, Jeong WI, Chung JY, Park SJ, Hong IH, Jeon SK, Lee IS, Jeong KS: Bone-protecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts. Menopause. 2008, 15: 676-83.
Article
PubMed
Google Scholar
Faloni AP, Sasso-Cerri E, Katchburian E, Cerri PS: Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats. J Periodontal Res. 2007, 42: 193-201. 10.1111/j.1600-0765.2006.00932.x.
Article
CAS
PubMed
Google Scholar
Penolazzi L, Magri E, Lambertini E, Bianchini E, Piva R, Gambari R: "In vivo" local transfection of a cis element decoy mimicking an estrogen receptor alpha gene promoter region induces apoptosis of osteoclasts following application of orthodontic forces to rat teeth. Apoptosis. 2006, 11: 1653-6. 10.1007/s10495-006-8763-2.
Article
CAS
PubMed
Google Scholar